A carregar...
EXTH-32. REPEAT ADENOSINE RECEPTOR ACTIVATION IMPROVES GBM SURVIVAL IN MICE BY TRANSIENTLY MODULATING THE BLOOD-BRAIN BARRIER
BACKGROUND: Glioblastoma (GBM) has a poor prognosis partly due to inadequate chemotherapy delivery across the blood-brain barrier (BBB). Previous studies using an adenosine A(2A) receptor (A(2A)R) agonist, regadenoson, impacted tight/adherens junctions and multi-drug resistance (MDR) proteins after...
Na minha lista:
Publicado no: | Neuro Oncol |
---|---|
Main Authors: | , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Oxford University Press
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692259/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.324 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|